Literature DB >> 24486384

The recovery of acetylcholinesterase activity and the progression of neuropathological and pathophysiological alterations in the rat basolateral amygdala after soman-induced status epilepticus: relation to anxiety-like behavior.

Eric M Prager1, Vassiliki Aroniadou-Anderjaska2, Camila P Almeida-Suhett1, Taiza H Figueiredo3, James P Apland4, Franco Rossetti3, Cara H Olsen5, Maria F M Braga6.   

Abstract

Organophosphorus nerve agents are powerful neurotoxins that irreversibly inhibit acetylcholinesterase (AChE) activity. One of the consequences of AChE inhibition is the generation of seizures and status epilepticus (SE), which cause brain damage, resulting in long-term neurological and behavioral deficits. Increased anxiety is the most common behavioral abnormality after nerve agent exposure. This is not surprising considering that the amygdala, and the basolateral nucleus of the amygdala (BLA) in particular, plays a central role in anxiety, and this structure suffers severe damage by nerve agent-induced seizures. In the present study, we exposed male rats to the nerve agent soman, at a dose that induce SE, and determined the time course of recovery of AChE activity, along with the progression of neuropathological and pathophysiological alterations in the BLA, during a 30-day period after exposure. Measurements were taken at 24 h, 7 days, 14 days, and 30 days after exposure, and at 14 and 30 days, anxiety-like behavior was also evaluated. We found that more than 90% of AChE is inhibited at the onset of SE, and AChE inhibition remains at this level 24 h later, in the BLA, as well as in the hippocampus, piriform cortex, and prelimbic cortex, which we analyzed for comparison. AChE activity recovered by day 7 in the BLA and day 14 in the other three regions. Significant neuronal loss and neurodegeneration were present in the BLA at 24 h and throughout the 30-day period. There was no significant loss of GABAergic interneurons in the BLA at 24 h post-exposure. However, by day 7, the number of GABAergic interneurons in the BLA was reduced, and at 14 and 30 days after soman, the ratio of GABAergic interneurons to the total number of neurons was lower compared to controls. Anxiety-like behavior in the open-field and the acoustic startle response tests was increased at 14 and 30 days post-exposure. Accompanying pathophysiological alterations in the BLA - studied in in vitro brain slices - included a reduction in the amplitude of field potentials evoked by stimulation of the external capsule, along with prolongation of their time course and an increase in the paired-pulse ratio. Long-term potentiation was impaired at 24 h, 7 days, and 14 days post-exposure. The loss of GABAergic interneurons in the BLA and the decreased interneuron to total number of neurons ratio may be the primary cause of the development of anxiety after nerve agent exposure. Published by Elsevier Ltd.

Entities:  

Keywords:  Acetylcholinesterase; Anxiety; Basolateral amygdala; Long-term potentiation; Soman; Status epilepticus

Mesh:

Substances:

Year:  2014        PMID: 24486384      PMCID: PMC4005290          DOI: 10.1016/j.neuropharm.2014.01.035

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  93 in total

Review 1.  Neurotransmission in the rat amygdala related to fear and anxiety.

Authors:  M Davis; D Rainnie; M Cassell
Journal:  Trends Neurosci       Date:  1994-05       Impact factor: 13.837

Review 2.  Nerve agent intoxication: recent neuropathophysiological findings and subsequent impact on medical management prospects.

Authors:  Jean-Marc Collombet
Journal:  Toxicol Appl Pharmacol       Date:  2011-07-26       Impact factor: 4.219

3.  Afterdischarge thresholds and kindling rates in dorsal and ventral hippocampus and dentate gyrus.

Authors:  R Racine; P A Rose; W M Burnham
Journal:  Can J Neurol Sci       Date:  1977-11       Impact factor: 2.104

4.  Post-traumatic stress disorder symptoms in victims of Tokyo subway attack: a 5-year follow-up study.

Authors:  Toshiyuki Ohtani; Akira Iwanami; Kiyoto Kasai; Hidenori Yamasue; Tadafumi Kato; Tsukasa Sasaki; Nobumasa Kato
Journal:  Psychiatry Clin Neurosci       Date:  2004-12       Impact factor: 5.188

5.  Primary brain targets of nerve agents: the role of the amygdala in comparison to the hippocampus.

Authors:  Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; James P Apland; Felicia Qashu; Maria F M Braga
Journal:  Neurotoxicology       Date:  2009-07-08       Impact factor: 4.294

6.  Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting.

Authors:  L E Mello; E A Cavalheiro; A M Tan; W R Kupfer; J K Pretorius; T L Babb; D M Finch
Journal:  Epilepsia       Date:  1993 Nov-Dec       Impact factor: 5.864

7.  Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function.

Authors:  M Ankarcrona; J M Dypbukt; E Bonfoco; B Zhivotovsky; S Orrenius; S A Lipton; P Nicotera
Journal:  Neuron       Date:  1995-10       Impact factor: 17.173

8.  Recovery of acetylcholinesterase in the diaphragm, brain, and plasma of the rat after irreversible inhibition by soman: a study of cytochemical localization and molecular forms of the enzyme in the motor end plate.

Authors:  Z Grubić; J Sketelj; B Klinar; M Brzin
Journal:  J Neurochem       Date:  1981-10       Impact factor: 5.372

9.  Up-regulation of D-serine might induce GABAergic neuronal degeneration in the cerebral cortex and hippocampus in the mouse pilocarpine model of epilepsy.

Authors:  Yong-Hong Liu; Lian Wang; Li-Chun Wei; Yuan-Gui Huang; Liang-Wei Chen
Journal:  Neurochem Res       Date:  2009-01-03       Impact factor: 3.996

Review 10.  Top-down modulation of prepulse inhibition of the startle reflex in humans and rats.

Authors:  Liang Li; Yi Du; Nanxin Li; Xihong Wu; Yanhong Wu
Journal:  Neurosci Biobehav Rev       Date:  2009-02-11       Impact factor: 8.989

View more
  22 in total

1.  Intranasal delivery of obidoxime to the brain prevents mortality and CNS damage from organophosphate poisoning.

Authors:  Jishnu K S Krishnan; Peethambaran Arun; Abhilash P Appu; Nivetha Vijayakumar; Taíza H Figueiredo; Maria F M Braga; Sudikshya Baskota; Cara H Olsen; Natalia Farkas; John Dagata; William H Frey; John R Moffett; Aryan M A Namboodiri
Journal:  Neurotoxicology       Date:  2016-01-02       Impact factor: 4.294

2.  The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302.

Authors:  James P Apland; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Franco Rossetti; Steven L Miller; Maria F M Braga
Journal:  J Pharmacol Exp Ther       Date:  2014-08-25       Impact factor: 4.030

3.  Pathophysiological mechanisms underlying increased anxiety after soman exposure: reduced GABAergic inhibition in the basolateral amygdala.

Authors:  Eric M Prager; Volodymyr I Pidoplichko; Vassiliki Aroniadou-Anderjaska; James P Apland; Maria F M Braga
Journal:  Neurotoxicology       Date:  2014-08-20       Impact factor: 4.294

Review 4.  A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibition.

Authors:  Asheebo Rojas; Thota Ganesh; Wenyi Wang; Jennifer Wang; Raymond Dingledine
Journal:  Neurobiol Dis       Date:  2019-02-25       Impact factor: 5.996

5.  Midazolam-Resistant Seizures and Brain Injury after Acute Intoxication of Diisopropylfluorophosphate, an Organophosphate Pesticide and Surrogate for Nerve Agents.

Authors:  Xin Wu; Ramkumar Kuruba; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2018-08-16       Impact factor: 4.030

6.  Inhibition of the prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits in the novel object recognition task in rats.

Authors:  Asheebo Rojas; Thota Ganesh; Zahra Manji; Theon O'neill; Raymond Dingledine
Journal:  Neuropharmacology       Date:  2016-07-29       Impact factor: 5.250

7.  A rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonists.

Authors:  Steven L Miller; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Eric M Prager; Camila P Almeida-Suhett; James P Apland; Maria F M Braga
Journal:  Toxicol Appl Pharmacol       Date:  2015-02-15       Impact factor: 4.219

8.  The chemical convulsant diisopropylfluorophosphate (DFP) causes persistent neuropathology in adult male rats independent of seizure activity.

Authors:  Eduardo A González; Alexa C Rindy; Michelle A Guignet; Jonas J Calsbeek; Donald A Bruun; Ashish Dhir; Peter Andrew; Naomi Saito; Douglas J Rowland; Danielle J Harvey; Michael A Rogawski; Pamela J Lein
Journal:  Arch Toxicol       Date:  2020-04-18       Impact factor: 5.153

9.  A rodent model of human organophosphate exposure producing status epilepticus and neuropathology.

Authors:  W Pouliot; S L Bealer; B Roach; F E Dudek
Journal:  Neurotoxicology       Date:  2016-08-12       Impact factor: 4.294

10.  LY293558 prevents soman-induced pathophysiological alterations in the basolateral amygdala and the development of anxiety.

Authors:  Eric M Prager; Taiza H Figueiredo; Robert P Long; Vassiliki Aroniadou-Anderjaska; James P Apland; Maria F M Braga
Journal:  Neuropharmacology       Date:  2014-09-06       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.